The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health•

Category: Women’s Health

Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health
Finance

Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health

SEP 16, 2026
LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis
Editor's Choice

LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis

MAY 1, 2026
Freya Biosciences announces positive Phase 1 data for IVF-related embryo implantation failure
Clinical & Manufacturing

Freya Biosciences announces positive Phase 1 data for IVF-related embryo implantation failure

APR 16, 2026
Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment
Editor's Choice

Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment

APR 8, 2026
Women’s Health Innovation Is Not Failing – The System Around It Is
Finance

Women’s Health Innovation Is Not Failing – The System Around It Is

MAR 31, 2026
Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
Biotics and Supplements

Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence

MAR 24, 2026
Researchers Discover that Vaginal Bacteria Don’t Always Behave the Same Way
Pharma & Human Health

Researchers Discover that Vaginal Bacteria Don’t Always Behave the Same Way

FEB 5, 2026
The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
Editor's Choice

The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies

NOV 12, 2025
Global “sisterhood” seeks to understand what makes a healthy vaginal microbiome
Pharma & Human Health

Global “sisterhood” seeks to understand what makes a healthy vaginal microbiome

FEB 12, 2025
Changes in microbiome predict risk for sexually transmitted disease
Infectious Disease & AMR

Changes in microbiome predict risk for sexually transmitted disease

JAN 22, 2025
Freya Biosciences Announces $10.4 Million Strategic Investment from the Bill & Melinda Gates Foundation
Finance

Freya Biosciences Announces $10.4 Million Strategic Investment from the Bill & Melinda Gates Foundation

NOV 19, 2024